Maris-Tech Ltd. Form 6-K Summary
Business context and reporting period
Maris-Tech Ltd., an Israeli foreign private issuer, furnished this Form 6-K on August 17, 2023, for the month of August 2023. The filing reports corporate actions involving employee, director, and service-provider equity compensation.
Key financial and capital-market metrics
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other operating financial metrics.
- Existing option exercise prices held by certain officers, directors, and service providers were repriced from $4.20 to $1.00 per ordinary share.
- The repricing was approved by shareholders on June 28, 2023 and completed in July 2023.
- The number of ordinary shares reserved under the 2021 Share Option Plan increased by 491,500, from 308,500 to 800,000 shares.
Material changes versus the prior comparable period
No comparative financial-period information is presented. The material changes disclosed are the completed option repricing and the expanded share reserve under the Company’s 2021 Share Option Plan.
Guidance, outlook, risks, contingencies, and unusual items
- The repricing may increase the potential value of affected options and could create additional dilution if exercised.
- The increased share reserve expands the Company’s capacity to grant options and may result in future dilution.
- The filing provides no management guidance, operating outlook, financial contingency information, or quantified accounting impact from these actions.
- The filing and its exhibit were incorporated by reference into the Company’s Form S-8 and Form F-3 registration statements.
Facts investors should verify
- The number of options subject to the $1.00 repricing and the identities or categories of affected holders.
- The remaining unissued share capacity under the amended 2021 Share Option Plan.
- The potential dilution from repriced options and future awards.
- Any accounting expense, tax impact, or compensation-cost consequences arising from the repricing.
- The terms of the First Amendment to the 2021 Share Option Plan attached as Exhibit 10.1.